January 09, 2019 As takeover hopes build, 2018 provides a low bar to beat Takeda gave biopharma’s M&A bill a big boost in 2018 but to see just how slow the year was, take a look at deal volumes.
August 06, 2018 Almirall spots an opportunity The Spanish group shows again that there is a future in dermatology, but its Allergan deal really depends on the fate of one asset.
